Awasthi A - Search Results

1

Variable Expression of GLIPR1 Correlates with Invasive Potential in Melanoma Cells.

Awasthi A, Woolley AG, Lecomte FJ, Hung N, Baguley BC, Wilbanks SM, Jeffs AR, Tyndall JD. Awasthi A, et al. Front Oncol. 2013 Aug 30;3:225. doi: 10.3389/fonc.2013.00225. eCollection 2013. Front Oncol. 2013. PMID: 24010123 Free PMC article.

2

A gene expression signature of invasive potential in metastatic melanoma cells.

Jeffs AR, Glover AC, Slobbe LJ, Wang L, He S, Hazlett JA, Awasthi A, Woolley AG, Marshall ES, Joseph WR, Print CG, Baguley BC, Eccles MR. Jeffs AR, et al. Among authors: awasthi a. PLoS One. 2009 Dec 24;4(12):e8461. doi: 10.1371/journal.pone.0008461. PLoS One. 2009. PMID: 20041153 Free PMC article.

3

Revolutionizing the World of Pharmaceuticals: Unleashing the Game-Changing Power of 3D Printing.

Chauhan A, Verma A, Shekho D, Mishra R, Awasthi A. Chauhan A, et al. Among authors: awasthi a. Curr Drug Targets. 2024 May 6. doi: 10.2174/0113894501304163240429081741. Online ahead of print. Curr Drug Targets. 2024. PMID: 38712375 No abstract available.

4

DHA and Cancer: The Uncharted Territory of Nutritional Oncology.

Shekho D, Chauhan A, Mishra R, Awasthi A. Shekho D, et al. Among authors: awasthi a. Curr Pharm Biotechnol. 2024 Apr 26. doi: 10.2174/0113892010305256240422110943. Online ahead of print. Curr Pharm Biotechnol. 2024. PMID: 38676504 No abstract available.

5

SARS-CoV-2 infection induces thymic atrophy mediated by IFN-γ in hACE2 transgenic mice.

Rizvi ZA, Sadhu S, Dandotiya J, Sharma P, Binayke A, Singh V, Das V, Khatri R, Kumar R, Samal S, Kalia M, Awasthi A. Rizvi ZA, et al. Among authors: awasthi a. Eur J Immunol. 2024 Apr 24:e2350624. doi: 10.1002/eji.202350624. Online ahead of print. Eur J Immunol. 2024. PMID: 38655818

6

Cenicriviroc, a CCR2/CCR5 antagonist, promotes the generation of type 1 regulatory T cells.

Madan U, Verma B, Awasthi A. Madan U, et al. Among authors: awasthi a. Eur J Immunol. 2024 Apr 21:e2350847. doi: 10.1002/eji.202350847. Online ahead of print. Eur J Immunol. 2024. PMID: 38643381

7

Transcending Molecules: Paving the Way from Lab to Life in Drug Transport Innovation.

Verma A, Chauhan A, Awasthi A. Verma A, et al. Among authors: awasthi a. Curr Drug Targets. 2024 Apr 18. doi: 10.2174/0113894501305312240414073623. Online ahead of print. Curr Drug Targets. 2024. PMID: 38639289 No abstract available.

8

A Comprehensive Review of Total Hip Arthroplasty Outcomes in Post-traumatic Hip Arthritis: Insights and Perspectives.

Choudhary A, Pisulkar G, Taywade S, Awasthi AA, Salwan A. Choudhary A, et al. Among authors: awasthi aa. Cureus. 2024 Mar 17;16(3):e56350. doi: 10.7759/cureus.56350. eCollection 2024 Mar. Cureus. 2024. PMID: 38633974 Free PMC article. Review.

9

Patient-Centric Approaches: Revolutionizing Rare Disease Drug Research.

Verma A, Awasthi A. Verma A, et al. Among authors: awasthi a. Infect Disord Drug Targets. 2024 Apr 16. doi: 10.2174/0118715265296986240329060452. Online ahead of print. Infect Disord Drug Targets. 2024. PMID: 38629354 No abstract available.

10

CRISPR and Gene Editing: A Game-Changer in Drug Development.

Verma A, Sharma T, Awasthi A. Verma A, et al. Among authors: awasthi a. Curr Pharm Des. 2024 Apr 4. doi: 10.2174/0113816128298080240328053845. Online ahead of print. Curr Pharm Des. 2024. PMID: 38584552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

587 results

Search Page